News

The Pillars of Confidence global study assessed the role that confidence plays in daily life and how aesthetic treatments affect confidence.

In an interview with Dermatology Times, Del Rosso gave insight on off-label therapies that could be used to treat granuloma annulare.

The meta-analysis found that HA fillers enhance skin hydration and glow, but do not significantly impact elasticity.

“The Big See” campaign and the Seal of Recommendation program are just 2 examples of initiatives led by the Skin Cancer Foundation.

85% of Chinese PN patients saw a PP-NRS improvement of ≥ 4 points after 12 weeks of treatment.

Dermatology Times is recapping our top expert interviews from the month of January.

Discover insights from Gerry Muhle and Michael Somenek, MD, on regenerative aesthetics, weight-loss impacts, and trends shaping facial rejuvenation.

James Del Rosso, DO, explored the treatment landscape and the importance of regular eye exams for patients with AD.

The Foundation’s extensive library includes brochures, magazines, and posters to promote education among dermatologists and patients.

Investigators observed lowered MASI and PGA scores in the side of the face treated with BoNT-A.

As a part of his presentation at Winter Clinical Miami, Del Rosso discussed new and emerging therapies for acne vulgaris.

Muhle shares Galderma's study results on Sculptra and Restylane, showcasing regenerative aesthetics and personalized HIT treatments.

At the Horizons in Advanced Practice meeting, Douglas DiRuggiero, DMSc, MHS, PA-C, presented a case of a man aged 47 years with a history of moderate psoriasis for 3 years and a recent diagnosis of psoriatic arthritis

One of the Foundation’s top initiatives is its mobile skin cancer screening program, “Destination Healthy Skin.”

A new study explores an effective treatment protocol to restore volume and improve skin quality in patients experiencing facial changes from weight loss medications.

A new review highlights overall allergen rates among children in the United States between 2010 and 2024.

Noor noted patients benefit from in-house injection services, avoiding the inconvenience of traveling to off-site centers.

Galderma's Gerry Muhle addresses facial aesthetic needs linked to weight loss, focusing on personalized, regenerative treatments.

James Del Rosso, DO, shared insights on existing and upcoming therapies for seborrheic dermatitis.

Explore the top headlines of the week including clinical trial updates, social media hair trends, and expert insights.

In case you missed it, this week we had news about the link between psoriasis and dementia, the future of urticaria treatment, VP-315's positive results in basal cell carcinoma, and more.

More luminous skin with reduced fine lines and hyperpigmentation was seen as early as 2 weeks.

George Washington University recently earned a Skin Smart Campus designation, championing skin cancer prevention through education, free sunscreen, and UV safety measures.

Compared to minoxidil alone, the combination therapy saw no significant differences in hair count and diameter.

QRX003 mimics the LEKTI protein to strengthen skin barriers and alleviate symptoms in patients with Netherton Syndrome.

Personalized care is key to managing hyperhidrosis, blending therapies, addressing adverse effects, and empowering patients with tailored solutions.

Understanding urticaria subtypes, from spontaneous to inducible, is key to crafting patient-specific management plans.

At the Horizons in Advanced Practice meeting, Omar Noor, MD, FAAD, presented a case of a man aged 70 years with a 20-year history of psoriasis who was previously treated with adalimumab.

Combining synchronized radiofrequency with high intensity facial electrical stimulation led to firmer, smoother, and more lifted skin.

According to a phase 3 study, the omalizumab biosimilar saw comparable results with a good safety profile.